Incyte (INCY) Exchange Rate Effect (2016 - 2026)
Incyte (INCY) reported Exchange Rate Effect of -$2.7 million for Q1 2026, down 387.14% on a YoY basis from $936484.5 in Q1 2025, and down 235.71% quarter-over-quarter from -$801000.0 in Q4 2025.
Incyte (INCY) Exchange Rate Effect (2016 - 2026) Analysis & Trends
Incyte has reported Exchange Rate Effect for 11 years, with the latest figure at -$2.7 million in Q1 2026.
- For the quarter ending Q1 2026, Exchange Rate Effect fell 387.14% year-over-year to -$2.7 million; the trailing twelve-month figure through Mar 2026 stood at -$3.8 million (down 226.22% YoY), and the FY2025 full-year result was -$1.7 million, down 158.47% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at -$2.7 million, down from -$801000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $3.5 million in Q4 2024, with the low at -$7.3 million in Q4 2023.
- Historically, Exchange Rate Effect has averaged -$282117.6 across 5 years, with a median of $13000.0 in 2024.
- The largest YoY upside for Exchange Rate Effect was 557.03% in 2025 against a maximum downside of 9307.69% in 2025.
- Incyte's Exchange Rate Effect stood at $627000.0 in 2022, then tumbled by 1264.43% to -$7.3 million in 2023, then jumped by 147.36% to $3.5 million in 2024, then plunged by 123.16% to -$801000.0 in 2025, then tumbled by 235.71% to -$2.7 million in 2026.
- The last three Exchange Rate Effect figures came in at -$2.7 million (Q1 2026), -$801000.0 (Q4 2025), and $841000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | Incyte | 19.62 Bn | 15.60 Bn | 1.17 Bn | -2.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.69 Mn |
| Mar 31, 2026 | -2.69 Mn |
| Dec 31, 2025 | -801,000.00 |
| Dec 31, 2025 | -801,000.00 |
| Sep 30, 2025 | 841,000.00 |
| Sep 30, 2025 | 841,000.00 |
| Jun 30, 2025 | -1.20 Mn |
| Jun 30, 2025 | -1.20 Mn |
| Mar 31, 2025 | -552,000.00 |
| Mar 31, 2025 | -552,000.00 |
| Dec 31, 2024 | 3.46 Mn |
| Dec 31, 2024 | 3.46 Mn |
| Sep 30, 2024 | 128,000.00 |
| Sep 30, 2024 | 128,000.00 |
| Jun 30, 2024 | 13,000.00 |
| Jun 30, 2024 | 13,000.00 |
| Mar 31, 2024 | -676,000.00 |
| Mar 31, 2024 | -676,000.00 |
| Dec 31, 2023 | -7.30 Mn |
| Dec 31, 2023 | -7.30 Mn |